Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Randomized, Single-Blind, Superiority Study Comparing The Efficacy And Tolerability Of A New Drug Containing The Combination Meloxicam And Cyclobenzaprine And The Same Components Alone In The Treatment Of Acute Lumbago

Next Previous
X
Search
Trial Profile

A Phase III, Randomized, Single-Blind, Superiority Study Comparing The Efficacy And Tolerability Of A New Drug Containing The Combination Meloxicam And Cyclobenzaprine And The Same Components Alone In The Treatment Of Acute Lumbago

Status: Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 04 May 2016

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cyclobenzaprine/meloxicam (Primary) ; Cyclobenzaprine; Meloxicam
  • Indications Back pain
  • Focus Therapeutic Use
  • Sponsors Eurofarma

    • Most Recent Events

    • 29 Apr 2016 Status changed from not yet recruiting to withdrawn prior to enrolment because the comparator product was withdrawn from the brazilian market not being possible to conduct the design regarding initially planned
    • 24 Jul 2015 Planned primary completion date changed from 1 Jun 2013 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
    • 24 Jul 2015 Planned End Date changed from 1 Sep 2013 to 1 Jun 2017 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top